Microneedling for Burn Scars
Trial Summary
Do I need to stop my current medications for the trial?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are on anticoagulant medications (blood thinners).
What data supports the effectiveness of the treatment Microneedling for burn scars?
Is microneedling safe for treating burn scars?
How is microneedling treatment for burn scars different from other treatments?
Microneedling is unique because it uses tiny needles to create micro-injuries in the skin, which triggers the body's natural healing process, leading to increased collagen production and improved scar appearance. This minimally invasive approach offers a way to remodel scars with minimal downtime compared to more invasive procedures.234910
What is the purpose of this trial?
Approximately 33 to 91% of severe burn victims will develop hypertrophic scars. Hypertrophic scars are defined as erythematous (red), raised and rigid scars that can cause pain and itching, among other things. They cause psychological distress and affect the quality of life of burn victims. Microneedling is a technique that uses an electrical device to create hundreds of microchannels that penetrate the skin layers. This study is interested in determining the effectiveness of microneedling in improving the pliability, thickness and erythema of hypertrophic scars. Each scar will receive up to 5 ACS-pen treatments followed by the application of cortisone (triamcinolone acetonide). Knowing that microneedling increases the absorption of products applied to the skin by about 80%, it is logical to think that creating these channels to the dermis and applying cortisone afterwards would have a beneficial effect on the hypertrophic scars of these patients.
Eligibility Criteria
This trial is for individuals aged 16 or older with at least two hypertrophic scars from burns, who can consent to treatment. It's not suitable for those with keloid scars, mature scar sites, certain psychiatric or cognitive impairments, skin conditions like psoriasis or eczema near the scar site, allergies to ultrasound gel, language barriers in English or French, or those on anticoagulants.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive microneedling treatments every six weeks for a maximum of five treatments, followed by the application of cortisone
Follow-up
Participants are monitored for changes in skin elasticity, thickness, and erythema after treatment
Treatment Details
Interventions
- Microneedling
Microneedling is already approved in United States, European Union, Canada for the following indications:
- Facial rejuvenation
- Acne scars
- Burn scars
- Hypertrophic scars
- Skin rejuvenation
- Scars
- Burn scars
- Hypertrophic scars
- Cosmetic skin treatments
- Scars
- Burn scars
Find a Clinic Near You
Who Is Running the Clinical Trial?
Centre hospitalier de l'Université de Montréal (CHUM)
Lead Sponsor